Philips CPAP Mass Tort Case Leads
Connect with patients who used recalled Philips Respironics sleep and respiratory devices containing degrading PE-PUR sound abatement foam.
Philips CPAP, BiPAP, and Ventilator Recall Litigation
Philips Respironics recalled roughly 15 million CPAP, BiPAP, and mechanical ventilator devices worldwide beginning in June 2021 — about 10.8 million of them in the United States — after determining that the polyester-based polyurethane (PE-PUR) foam used to dampen device noise could degrade into particles and release volatile organic compounds that users then inhaled. Federal claims are consolidated in MDL 3014 before Judge Joy Flowers Conti in the Western District of Pennsylvania. Firms should note the docket's advanced posture: Philips agreed to a personal injury settlement of approximately $1.1 billion, comprising about $1.075 billion for personal injury claims and $25 million for medical monitoring, and the registration deadline for that program closed on January 31, 2025. As of July 2026 there were 623 cases pending in the MDL, and the litigation sits largely in claims administration and wind-down. Remaining contested activity centers on cancer claims, for which no court-approved settlement offers have been issued.
Associated Conditions
- Cancers alleged in the litigation, including lung, kidney, liver, and hematologic cancers
- Pulmonary fibrosis and other chronic lung damage
- Respiratory failure or persistent reactive airway disease
- Chronic cough, chest pressure, or sinus infection
- Headache, dizziness, or irritation of the airway
- Inhalation or ingestion of visible black foam particles
- Documented long-term use of a recalled device before the June 2021 recall
Claimant Eligibility
- Used a recalled Philips Respironics CPAP, BiPAP, or mechanical ventilator (recall announced June 2021)
- Sustained use — generally continuous nightly use over an extended period rather than occasional use
- Diagnosed with a qualifying cancer or serious respiratory injury after the period of device use
- Device registration, purchase records, prescription, or supplier records establishing the specific model
- Claim viability reviewed against the closed settlement registration deadline of January 31, 2025
Why Law Firms Choose Us
Exclusive Leads
Every lead is yours alone. We never resell or share claimant information with competing firms, guaranteeing you first-mover advantage on every case.
Pre-Qualified Claimants
Our intake specialists screen every potential claimant against your specific case criteria before delivery, so your team only speaks with viable cases.
Live Transfer
Qualified claimants are transferred directly to your intake team in real time, maximizing conversion rates and reducing time-to-retainer.
Philips CPAP legal marketing campaigns: how we acquire cases
Philips CPAP case acquisition runs as a multi-channel program, not a single ad buy. Product liability and class action claimants research their condition long before they contact a lawyer, so we meet potential clients at each stage — paid demand capture for people already searching, paid social and traditional media for people who have not yet connected their injury to the litigation, and organic search for the long research tail.
Digital marketing channels
- Google Ads and paid search demand capture
- Meta and paid social prospecting by exposure profile
- Mass tort search engine optimization for the research tail
- OTT and connected TV retargeting
Traditional media channels
- Broadcast and cable TV in qualifying DMAs
- Radio and streaming audio
- Direct response print in occupational verticals
- Earned media and litigation PR support
How the channel mix is built, budgeted, and measured is covered in our mass tort marketing guide. For intake handling once the lead lands, see mass tort intake.
Philips CPAP Lawsuit Updates (August 2026)
Current status of the Philips CPAP litigation, tracked monthly so your intake team and marketing spend stay aligned with where the docket actually is.
- MDL
- MDL 3014
- Court
- W.D. Pa.
Current posture: Settlement funding in place; registration deadlines have closed for the settled tracks.
Settlement funding of approximately $1.075 billion is in place for the Philips Respironics personal injury track, with payout timing running through the settlement administrator. Registration deadlines for the settled tracks have closed.
A separate $479 million settlement resolved economic-loss claims tied to the recalled CPAP, BiPAP, and mechanical ventilator devices, administered independently of the personal injury track.
Case counts and procedural posture are compiled from JPML MDL statistics reporting and public court dockets, and are provided for law firm campaign planning. This is not legal advice and is not a prediction of any case outcome.
Running a Philips CPAP mass tort marketing campaign
Common questions from law firms about Philips CPAP lawsuit lead generation and campaign management.
- What does a Philips CPAP mass tort marketing campaign include?
- A Philips CPAP mass tort marketing campaign from Mass Tort Marketing Agency covers multi-channel strategy across Meta, Google PPC, OTT and connected TV, traditional media, and mass tort search engine optimization; compliant ad creative; TCPA-verified intake; claimant qualification against your Philips CPAP case criteria; and signed-retainer reporting. Performance is measured on cost per signed retainer, not raw lead volume.
- How do you generate Philips CPAP mass tort case leads?
- Philips CPAP mass tort case leads are generated through paid social and search campaigns aimed at the specific exposure and injury profile of the litigation, supported by organic content that captures claimants already researching their condition. Every lead is a real, consented claimant — we do not buy aggregated lists or resell shared data.
- What do Philips CPAP legal marketing campaigns cost?
- Philips CPAP legal marketing campaigns are quoted and reported on cost per signed retainer (CPSR), so spend ties directly to signed cases rather than lead count. Cost per retainer varies by tort based on claimant prevalence, media competition, and how tight your case criteria are. We scope a per-tort figure before any spend commitment.
- Are Philips CPAP leads exclusive to my firm?
- Yes. Every Philips CPAP lead is delivered to one firm only — never resold, syndicated, or shared with competing firms. Your firm owns the contact data, consent records, and call recordings.
- How are Philips CPAP claimants qualified before delivery?
- Each Philips CPAP claimant is screened against tort-specific facts (exposure windows, injury markers, and state eligibility) and carries a certified TrustedForm or Jornaya consent record — preserving the exact disclosure language shown at submission — before the lead reaches your intake team.
- How fast can a Philips CPAP case acquisition program scale?
- A Philips CPAP mass tort case acquisition program typically moves from scoping to live media inside two weeks, with volume ramped against your docket capacity rather than pushed to a fixed budget. Volume can be scaled up or down by tort month to month as the litigation posture changes.
- Is the Philips CPAP litigation still open to new claimants?
- Only in a narrow sense, and firms should plan campaigns accordingly. The registration window for the approximately $1.1 billion personal injury settlement program closed on January 31, 2025, so claimants who did not register by that date cannot participate in it. The MDL still had 623 cases pending as of July 2026 and cancer claims remain contested with no court-approved offers, but this is a wind-down docket rather than an open intake opportunity. We will flag that before you commit budget — for most firms Philips CPAP is a topical authority and referral-capture page rather than a primary acquisition campaign.
- How are Philips CPAP claimants qualified given the closed registration deadline?
- Intake screens first on whether the claimant previously registered in the settlement program or retained prior counsel, because that single fact determines whether a file has any path forward. Files are then verified on device model and recall status, duration of use, and the diagnosis and its timing relative to use. Claimants who missed registration and hold no viable independent claim are screened out rather than delivered — your firm makes the final eligibility determination.
Get Philips CPAP campaign pricing on a 30-minute call
We will walk your Philips CPAP case criteria, current cost per signed retainer, and the volume your docket can absorb — and tell you plainly if this tort is not a fit right now.
See how every lead is qualified on our mass tort leads page, read the full mass tort marketing guide, or compare providers in our top mass tort marketing firms guide.